株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

分子生物学用酵素・キット・試薬の世界市場 2022年:ポリメラーゼ連鎖反応 (PCR) ・シークエンシング・クローニング・エピジェネティクス

Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), Region - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 310758
出版日 ページ情報 英文 176 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.40円で換算しております。
Back to Top
分子生物学用酵素・キット・試薬の世界市場 2022年:ポリメラーゼ連鎖反応 (PCR) ・シークエンシング・クローニング・エピジェネティクス Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), Region - Global Forecast to 2022
出版日: 2017年10月10日 ページ情報: 英文 176 Pages
概要

世界における分子生物学用酵素・キット・試薬の市場規模は、2017年の65億2,000万米ドルから2022年までに136億米ドルに達すると予測され、予測期間中のCAGR (年間複合成長率) は15.8%が見込まれています。同市場の成長には、ライフサイエンス産業における研究活動とR&D投資の増加、ゲノムプロジェクト数の増加、ライフサイエンス産業における技術進歩、および感染症・遺伝性疾患の発生率の増加などの要因が起因しています。しかし、遺伝子検査に対する医療費償還の制限は、予測期間中の同市場の成長を抑制すると予測されています。

当レポートは、世界の分子生物学用酵素・キット・試薬市場について調査分析し、市場の概要、用途・エンドユーザー・製品・地域別の調査を提供しており、競合情勢の分析と主要企業のプロファイル、および今後の市場展望も含め、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 分子生物学用酵素・キット・試薬:市場概要
  • アジア太平洋市場における分子生物学用酵素・キット・試薬:用途・国別
  • 分子生物学用酵素・キット・試薬市場:用途別
  • 分子生物学用酵素・キット・試薬市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場成長促進要因
  • 市場成長阻害要因
  • 機会
  • 課題

第6章 分子生物学用酵素・キット・試薬市場:製品別

  • イントロダクション
  • キット・試薬
  • 酵素
    • ポリメラーゼ
    • リガーゼ
    • 制限エンドヌクレアーゼ
    • 逆転写酵素
    • ホスファターゼ
    • プロテアーゼおよびプロテイナーゼ
    • その他の酵素

第7章 世界の分子生物学用酵素・キット・試薬市場予測:用途別

  • イントロダクション
  • ポリメラーゼ連鎖反応 (PCR)
  • シークエンシング
  • クローニング
  • エピジェネティックス
  • 制限消化
  • 合成生物学
  • その他のアプリケーション

第8章 世界の分子生物学用酵素・キット・試薬市場予測:エンドユーザー別

  • イントロダクション
  • 学術研究機関
  • 病院・診断センター
  • 医薬品・バイオテクノロジー企業
  • その他のエンドユーザー

第9章 分子生物学用酵素・キット・試薬市場予測:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (RoW)

第10章 競合情勢

  • イントロダクション
  • 市場シェア分析

第11章 企業プロファイル

  • THERMO FISHER SCIENTIFIC, INC.
  • MERCK KGAA
  • PROMEGA CORPORATION
  • NEW ENGLAND BIOLABS, INC.
  • ILLUMINA, INC.
  • タカラバイオ
  • QIAGEN N.V.
  • AGILENT TECHNOLOGIES, INC.
  • F. HOFFMANN-LA ROCHE LTD
  • BECTON, DICKINSON AND COMPANY

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2612

"The molecular biology enzymes and kits & reagents market projected to grow at a CAGR of 15.8%."

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 billion by 2022 from USD 6.52 billion in 2017, at a CAGR of 15.8% during the forecast period. The key factors driving the growth of this market include increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. However, limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

"By application, the sequencing segment to witness the highest growth during the forecast period (2017-2022)."

Based on application, the market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection). The sequencing segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing DNA sequencing with growth in genomic research, rapid technological advancements, decreasing costs of sequencing, and growing use of whole-genome sequencing and personalized genome sequencing.

"Asia Pacific (APAC) to witness the highest growth during the forecast period (2017-2022)"

Asia Pacific is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the APAC market is attributed to increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and growing outsourcing of clinical research activities to Asian countries.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-50%, Tier 2-30% and Tier 3-20%
  • By Designation - C-level-30%, Director Level-48%, Others-22%
  • By Region - North America-48%, Europe-20%, Asia Pacific-25%, RoW-7%

The key players in the global molecular biology enzymes and kits & reagents market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

Research Coverage:

The report analyzes the molecular biology enzymes and kits & reagents market and aims at estimating market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the molecular biology enzymes and kits & reagents market. The report analyzes the market based on product, application, and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the molecular biology enzymes and kits & reagents market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various molecular biology enzymes and kits & reagents across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the molecular biology enzymes and kits & reagents market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the molecular biology enzymes and kits & reagents market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DESIGN
  • 2.2. RESEARCH APPROACH
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Primary sources
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS: MARKET OVERVIEW
  • 4.2. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS IN ASIA PACIFIC MARKET, BY APPLICATION AND COUNTRY, 2017
  • 4.3. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2017 VS. 2022
  • 4.4. GEOGRAPHIC SNAPSHOT OF THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. DRIVERS
    • 5.2.1. INCREASED RESEARCH ACTIVITIES AND R&D INVESTMENTS IN THE LIFE SCIENCE INDUSTRY
    • 5.2.2. GROWING NUMBER OF GENOME PROJECTS
    • 5.2.3. TECHNOLOGICAL ADVANCEMENTS IN THE LIFE SCIENCE INDUSTRY
    • 5.2.4. RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS
  • 5.3. RESTRAINTS
    • 5.3.1. LIMITED REIMBURSEMENTS FOR GENETIC TESTING
  • 5.4. OPPORTUNITIES
    • 5.4.1. INCREASED USE OF PERSONALIZED MEDICINE
    • 5.4.2. DEVELOPING COUNTRIES OFFER SIGNIFICANT OPPORTUNITIES FOR THE MARKET
  • 5.5. CHALLENGES
    • 5.5.1. PRIVACY ISSUES RELATED TO GENETIC INFORMATION

6. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. KITS & REAGENTS
  • 6.3. ENZYMES
    • 6.3.1. POLYMERASES
    • 6.3.2. LIGASES
    • 6.3.3. RESTRICTION ENDONUCLEASES
    • 6.3.4. REVERSE TRANSCRIPTASES
    • 6.3.5. PHOSPHATASES
    • 6.3.6. PROTEASES AND PROTEINASES
    • 6.3.7. OTHER ENZYMES

7. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. POLYMERASE CHAIN REACTION
  • 7.3. SEQUENCING
  • 7.4. CLONING
  • 7.5. EPIGENETICS
  • 7.6. RESTRICTION DIGESTION
  • 7.7. SYNTHETIC BIOLOGY
  • 7.8. OTHER APPLICATIONS

8. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. ACADEMIC & RESEARCH INSTITUTES
  • 8.3. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.4. HOSPITALS & DIAGNOSTIC CENTERS
  • 8.5. OTHER END USERS

9. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. Increasing funding for genomics research
      • 9.2.1.2. Growth in the number of pharmaceutical and biotechnology companies
      • 9.2.1.3. Favorable reimbursement scenario for molecular diagnostics and growing prevalence of target indications in the US
    • 9.2.2. CANADA
      • 9.2.2.1. Investments in research projects
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Presence of a large number of academic and research institutes
      • 9.3.1.2. Increasing pharmaceutical R&D
      • 9.3.1.3. Venture capital investments in Germany
    • 9.3.2. UK
      • 9.3.2.1. Funding for research activities
      • 9.3.2.2. Increasing adoption of molecular diagnostics for cancer diagnosis in the UK
      • 9.3.2.3. The 100,000 genomes project
    • 9.3.3. FRANCE
      • 9.3.3.1. Presence of a large cancer patient population
      • 9.3.3.2. Genomic Medicine 2025 plan
    • 9.3.4. ROE
      • 9.3.4.1. Large biotechnology and pharmaceutical industry in Italy
      • 9.3.4.2. Growth in the Spanish biotechnology industry
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
      • 9.4.1.1. Increasing government interest in biomedical and biotechnology industries
      • 9.4.1.2. Outsourcing of clinical research activities to China
    • 9.4.2. JAPAN
      • 9.4.2.1. Involvement of industry players in the Japanese market
      • 9.4.2.2. Focus on cancer research and treatment
    • 9.4.3. INDIA
      • 9.4.3.1. Growing pharmaceutical industry in India, government initiatives
      • 9.4.3.2. Development of bio-clusters to propel the biotechnology industry in India
    • 9.4.4. ROAPAC
      • 9.4.4.1. The Genome Asia 100K Initiative
      • 9.4.4.2. Alliances and partnerships in molecular biology applications to boost the Australian market
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. INVESTMENTS IN RESEARCH & INNOVATION CENTERS AND CONFERENCES & WORKSHOPS IN BRAZIL
    • 9.5.2. RISING PREVALENCE OF CONDITIONS INVOLVING MOLECULAR DIAGNOSTICS IN AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. MARKET SHARE ANALYSIS, 2016

11. COMPANY PROFILES (Business Overview, Products offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*

  • 11.1. THERMO FISHER SCIENTIFIC, INC.
  • 11.2. MERCK KGAA
  • 11.3. PROMEGA CORPORATION
  • 11.4. NEW ENGLAND BIOLABS
  • 11.5. ILLUMINA, INC.
  • 11.6. TAKARA BIO, INC.
  • 11.7. QIAGEN N.V.
  • 11.8. AGILENT TECHNOLOGIES, INC.
  • 11.9. F. HOFFMANN-LA ROCHE LTD
  • 11.10. BIO BASIC INC.
  • 11.11. JENA BIOSCIENCE GMBH
  • 11.12. MOLECULAR BIOLOGY RESOURCES, INC.

*Details on Business Overview, Products offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GOVERNMENT FUNDING FOR PERSONALIZED MEDICINE
  • TABLE 2: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 3: MOLECULAR BIOLOGY KITS & REAGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: MOLECULAR BIOLOGY ENZYMES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: MOLECULAR BIOLOGY ENZYMES MARKET FOR POLYMERASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: MOLECULAR BIOLOGY ENZYMES MARKET FOR LIGASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: MOLECULAR BIOLOGY ENZYMES MARKET FOR RESTRICTION ENDONUCLEASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: MOLECULAR BIOLOGY ENZYMES MARKET FOR REVERSE TRANSCRIPTASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: MOLECULAR BIOLOGY ENZYMES MARKET FOR PHOSPHATASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: MOLECULAR BIOLOGY ENZYMES MARKET FOR PROTEASES AND PROTEINASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: MOLECULAR BIOLOGY ENZYMES MARKET FOR OTHER ENZYMES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 14: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR PCR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SEQUENCING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR CLONING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR EPIGENETICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR RESTRICTION DIGESTION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR SYNTHETIC BIOLOGY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 22: ACADEMIC & RESEARCH INSTITUTES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: HOSPITALS & DIAGNOSTIC CENTERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: OTHER END USERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 31: FUNDING FOR GENOMICS-RELATED PROJECTS
  • TABLE 32: US: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 33: US: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: US: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: US: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 36: CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 37: CANADA: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: CANADA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 42: EUROPE: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: EUROPE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 46: GERMANY: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: GERMANY: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: UK: NUMBER OF MOLECULAR DIAGNOSTIC TESTS CONDUCTED BETWEEN 2011 AND 2014, BY CANCER TYPE
  • TABLE 50: UK: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 51: UK: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: UK: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 53: UK: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 54: FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 55: FRANCE: ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: FRANCE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 59: ROE: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 61: ROE: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 62: APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 63: APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 64: APAC: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 66: APAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 67: CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 68: CHINA: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 70: CHINA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 72: JAPAN: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 74: JAPAN: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 75: INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 76: INDIA: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 78: INDIA: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: ROAPAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 80: ROAPAC: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 81: ROAPAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: ROAPAC: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 83: HIV INFECTIONS AND AIDS-RELATED DEATHS IN THE MIDDLE EAST AND AFRICA, 2015
  • TABLE 84: ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 85: ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 86: ROW: MOLECULAR BIOLOGY ENZYMES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 87: ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 88: ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: KEY INDUSTRY INSIGHTS
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION
  • FIGURE 8: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY PRODUCT, 2017
  • FIGURE 9: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY APPLICATION, 2017 VS. 2022
  • FIGURE 10: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET, BY END USER, 2017 VS. 2022
  • FIGURE 11: GEOGRAPHIC SNAPSHOT OF THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET
  • FIGURE 12: INCREASE IN RESEARCH ACTIVITIES IN THE LIFE SCIENCE INDUSTRY IS A KEY GROWTH DRIVER OF THE MARKET
  • FIGURE 13: ACADEMIC & RESEARCH INSTITUTES SEGMENT TO DOMINATE THE ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET IN 2017
  • FIGURE 14: PCR WILL CONTINUE TO DOMINATE THE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET IN 2022
  • FIGURE 15: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 16: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: KITS & REAGENTS SEGMENT TO DOMINATE THE MARKET IN 2017
  • FIGURE 18: THE PCR APPLICATION SEGMENT TO DOMINATE THE MARKET IN 2017
  • FIGURE 19: ACADEMIC & RESEARCH INSTITUTES TO DOMINATE THE MARKET IN 2017
  • FIGURE 20: NORTH AMERICA ESTIMATED TO BE THE LARGEST REGIONAL MARKET FOR MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS IN 2017
  • FIGURE 21: NORTH AMERICAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT
  • FIGURE 22: NUMBER OF NEW PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN THE US, 2014-2016
  • FIGURE 23: EUROPEAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT
  • FIGURE 24: APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT
  • FIGURE 25: ROW: MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SNAPSHOT
  • FIGURE 26: GLOBAL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 27: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 28: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 29: ILLUMINA, INC.: COMPANY SNAPSHOT
  • FIGURE 30: TAKARA BIO, INC.: COMPANY SNAPSHOT
  • FIGURE 31: QIAGEN N.V.: COMPANY SNAPSHOT
  • FIGURE 32: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 33: F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
Back to Top